	Cerebrospinal Fluid Biomarkers of NLRP3 Pathway, Immune Dysregulation, and Neurodegeneration in Parkinson's Disease: A Meta-Analysis. Mov Disord Marinescu AM, Machado V, Pagano G, Muelhardt NM, Kustermann T, Mracsko EZ, Brockmann K, Shariati N, Anzures-Cabrera J, Zinnhardt B. PMID: 41317029 [PubMed - as supplied by publisher]
	Bipolar Disorder as a Long-Term Risk Factor for Parkinson's Disease: A Nationwide Case-Control Study. Mov Disord Jaakkola E, Koponen M, Kaasinen V, Hietala J, Hartikainen S, Tolppanen AM. PMID: 41317018 [PubMed - as supplied by publisher]
	Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK). Mov Disord Rascol O, Ory-Magne F, Meissner WG, Maltête D, Defebvre L, Azulay JP, Thobois S, Houeto JL, Thalamas C, Sommet A, Geny C, Damier P, Anheim M, Marquès A, Viallet F, Giroud M, Lefaucheur R, Costentin G, Spampinato U, Samier-Foubert A, Carrière N, Mutez E, Mariani LL, Eusebio A, Prange S, Benatru I, Charif M, Brefel-Courbon C, Fabbri M, Galitzky M, Rousseau V, Saubion A, Catala H, Ferreira JJ, Burn DJ, Corvol JC, PREMANDYSK Study Group. PMID: 41316871 [PubMed - as supplied by publisher]
	Dermal Alpha-Synuclein Aggregation in Seed Amplification Assays for Parkinson's Disease Subtype Differentiation. Eur J Neurol Vieregge M, Kuzkina A, Janzen A, Oertel WH, Sommerauer M, Volkmann J, Doppler K. PMID: 41316710 [PubMed - indexed for MEDLINE]
	Multi-Session whole body vibration program on Parkinson's disease symptoms: Systematic review and meta-analysis. J Bodyw Mov Ther González-García P, Heredia-Rizo AM, Garrido-Bueno A, Casuso-Holgado MJ, García-Bernal MI. PMID: 41316661 [PubMed - indexed for MEDLINE]
	Assessment of postural control in individuals with Parkinson's disease during functional activities under different attentional demands. J Bodyw Mov Ther Broto PG, Pereira LA, de Oliveira HAGA, Terra MB, Smaili SM. PMID: 41316648 [PubMed - indexed for MEDLINE]
	Acute effects of an aerobic dual task on processing speed and attention in Parkinson's disease: a randomised controlled trial study. J Bodyw Mov Ther Mollinedo-Cardalda I, Monge-Pereira E, Pereira-Pedro KP, Machado de Oliveira I. PMID: 41316559 [PubMed - indexed for MEDLINE]
	Aquatic functional assessment scale (AFAS): A proposal for adaptation to Parkinson's disease (AFAS-PD). J Bodyw Mov Ther Leveck GC, Zanardi da Silva A, Yamaguchi B, Israel VL. PMID: 41316554 [PubMed - indexed for MEDLINE]
	Limited predictive value of preoperative nigrosome integrity for motor outcomes in Parkinson's disease deep brain stimulation. NPJ Parkinsons Dis Hu CK, B Mohammed W, Bai Y, Schmidt F, Rodrigues TA, Kalia SK, Fasano A, Germann J, Alcaide-Leon P, Boutet A, Lozano AM. PMID: 41315429 [PubMed]
	Personalized management of Parkinson's disease. Prog Brain Res Chakraborty D, Roy PK, Das R, Mal C. PMID: 41314750 [PubMed - indexed for MEDLINE]
	Causal associations between sarcopenia and Parkinson's disease â€’ A two-sample Mendelian randomization study. Nutr Hosp Shi J, Wang Y. PMID: 41313343 [PubMed - as supplied by publisher]
	Evaluation and management of male sexual dysfunction in Parkinson's disease: A clinical road map. J Parkinsons Dis Rafetto AN, Murray GR, Ziegelmann MJ. PMID: 41313338 [PubMed - as supplied by publisher]
	Constructing a Personalized Treatment Rule for Initial Therapy in Early Parkinson's Disease. Pharmacotherapy Brehm ZP, Schneider RB, Venuto CS, Smith G, Pham CT, McDermott MP, Ertefaie A. PMID: 41312798 [PubMed - as supplied by publisher]
	PICALM polymorphisms are associated with susceptibility to parkinson's disease in the Northern Chinese Han population: a case-control study. BMC Med Genomics Yu R, Li Y, Cao Y, Kong Z, Zhou Y, Hou B, Xie A. PMID: 41310592 [PubMed - as supplied by publisher]
	Identification of the efficacy and safety of apomorphine in the treatment of Parkinson's disease via meta-analysis. BMC Neurol Li H, Zhang L, Jiang B, Jing L. PMID: 41310565 [PubMed - indexed for MEDLINE]
	Wearable inertial device for monitoring Parkinson's disease symptoms: a pilot study in a controlled environment. Sci Rep Poleur M, Gidaro T, Delstanche S, Gurruchaga JM, Tricot A, Bancel L, Palfi S, Servais L, Degos B. PMID: 41309883 [PubMed - as supplied by publisher]
	Small molecule inhibitors targeting alpha-synuclein aggregation: Progress and future outlook. Adv Protein Chem Struct Biol Hajam IB, Ahanger IA, Rasool U, Dar TA. PMID: 41309197 [PubMed - indexed for MEDLINE]
	Interpretable machine learning for cognitive impairment prediction in Parkinson's disease: a multicenter validation study with SHAP analysis. Front Aging Neurosci Wang Z, Yan J. PMID: 41306400 [PubMed]
	Transforming Care Across Countries: Lessons from the Integrated Care Networks for Parkinson's Disease Study (iCARE-PD). Mov Disord Dash D, Fabbri M, Saade J, van Munster M, Pedrosa D, R, Gal O, Ferreira JJ, Sánchez-Ferro Á, Lynch T, Eggers C, Singh A, Grimes D, Taljaard M, Rascol O, Mestre TA, iCARE. PMID: 41306100 [PubMed - as supplied by publisher]
	Functional Physical Rehabilitation and Self-Assessment of Physical Activity in Parkinson's Disease. Med Sci Monit Cholewa J, Uher I, Cholewa J, Polecho, Lasek-Bal A, Balcerzak W, Gorzkowska A. PMID: 41305872 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 55642

Page 1 of 2783



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy